BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11497260)

  • 1. Irofulven (6-hydroxymethylacylfulvene, MGI 114) induces caspase 8 and 9-mediated apoptosis in human pancreatic adenocarcinoma cells.
    Wang W; Waters SJ; MacDonald JR; Von Hoff DD; Strodel WE; Miller AR
    Anticancer Res; 2001; 21(3B):1789-94. PubMed ID: 11497260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irofulven (6-hydroxymethylacylfulvene, MGI 114)-induced apoptosis in human pancreatic cancer cells is mediated by ERK and JNK kinases.
    Wang W; Waters SJ; MacDonald JR; Roth C; Shentu S; Freeman J; Von Hoff DD; Miller AR
    Anticancer Res; 2002; 22(2A):559-64. PubMed ID: 12014623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irofulven induces apoptosis in breast cancer cells regardless of caspase-3 status.
    Herzig MC; Liang H; Johnson AE; Woynarowska B; Woynarowski JM
    Breast Cancer Res Treat; 2002 Jan; 71(2):133-43. PubMed ID: 11883439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FR901228, a novel histone deacetylase inhibitor, induces cell cycle arrest and subsequent apoptosis in refractory human pancreatic cancer cells.
    Sato N; Ohta T; Kitagawa H; Kayahara M; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
    Int J Oncol; 2004 Mar; 24(3):679-85. PubMed ID: 14767553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced antitumor activity of irofulven in combination with 5-fluorouracil and cisplatin in human colon and ovarian carcinoma cells.
    Poindessous V; Koeppel F; Raymond E; Cvitkovic E; Waters SJ; Larsen AK
    Int J Oncol; 2003 Nov; 23(5):1347-55. PubMed ID: 14532976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-mediated apoptosis and caspase-independent cell death induced by irofulven in prostate cancer cells.
    Liang H; Salinas RA; Leal BZ; Kosakowska-Cholody T; Michejda CJ; Waters SJ; Herman TS; Woynarowski JM; Woynarowska BA
    Mol Cancer Ther; 2004 Nov; 3(11):1385-96. PubMed ID: 15542777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular determination of activated caspases (IDAC) by flow cytometry using a pancaspase inhibitor labeled with FITC.
    Jayaraman S
    Cytometry A; 2003 Dec; 56(2):104-12. PubMed ID: 14608638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells: a caution in data interpretation.
    Pozarowski P; Huang X; Halicka DH; Lee B; Johnson G; Darzynkiewicz Z
    Cytometry A; 2003 Sep; 55(1):50-60. PubMed ID: 12938188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.
    Nyormoi O; Wang Z; Doan D; Ruiz M; McConkey D; Bar-Eli M
    Mol Cell Biol; 2001 Aug; 21(15):4856-67. PubMed ID: 11438643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-3-like activity determines the type of cell death following ionizing radiation in MOLT-4 human leukaemia cells.
    Coelho D; Holl V; Weltin D; Lacornerie T; Magnenet P; Dufour P; Bischoff P
    Br J Cancer; 2000 Sep; 83(5):642-9. PubMed ID: 10944606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.
    Huisman C; Ferreira CG; Bröker LE; Rodriguez JA; Smit EF; Postmus PE; Kruyt FA; Giaccone G
    Clin Cancer Res; 2002 Feb; 8(2):596-606. PubMed ID: 11839682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase and proteasome activity during staurosporin-induced apoptosis in lens epithelial cells.
    Andersson M; Sjöstrand J; Petersen A; Honarvar AK; Karlsson JO
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2623-32. PubMed ID: 10937575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein produces reduction in growth and induces apoptosis of rat RPE-J cells.
    Yoon HS; Rho SH; Jeong JH; Yoon S; Yoo KS; Yoo YH
    Curr Eye Res; 2000 Mar; 20(3):215-24. PubMed ID: 10694898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB inhibitor sesquiterpene parthenolide induces concurrently atypical apoptosis and cell necrosis: difficulties in identification of dead cells in such cultures.
    Pozarowski P; Halicka DH; Darzynkiewicz Z
    Cytometry A; 2003 Aug; 54(2):118-24. PubMed ID: 12879458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation.
    Bedner E; Smolewski P; Amstad P; Darzynkiewicz Z
    Exp Cell Res; 2000 Aug; 259(1):308-13. PubMed ID: 10942603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavopiridol potently induces small cell lung cancer apoptosis during S phase in a manner that involves early mitochondrial dysfunction.
    Litz J; Carlson P; Warshamana-Greene GS; Grant S; Krystal GW
    Clin Cancer Res; 2003 Oct; 9(12):4586-94. PubMed ID: 14555534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induction by the dual-action DNA- and protein-reactive antitumor drug irofulven is largely Bcl-2-independent.
    Herzig MC; Trevino AV; Liang H; Salinas R; Waters SJ; MacDonald JR; Woynarowska BA; Woynarowski JM
    Biochem Pharmacol; 2003 Feb; 65(4):503-13. PubMed ID: 12566077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells.
    Ho TS; Ho YP; Wong WY; Chi-Ming Chiu L; Wong YS; Eng-Choon Ooi V
    Biomed Pharmacother; 2007 Oct; 61(9):578-87. PubMed ID: 17904792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer.
    Wu XX; Kakehi Y; Mizutani Y; Kamoto T; Kinoshita H; Isogawa Y; Terachi T; Ogawa O
    Int J Oncol; 2002 May; 20(5):949-54. PubMed ID: 11956588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
    Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.